November 24, 2015 – The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals’ ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
FDA Approves Dabigatran for Prophylaxis of DVT, Pulmonary Embolism and After Hip Replacement Surgery
November 24, 2015
November 20, 2015 — Boston Heart Diagnostics announced the launch of StatinSmart, an at-home saliva laboratory developed ...
November 20, 2015
Feature | Holter Monitoring Systems | Judy Lenane, RN, MHA
One-third of ischemic strokes are classified as cryptogenic. The classic risk factors for stroke are usually absent ...
November 16, 2015November 12, 2015 — Preventing blood clots with drugs such as heparin has become a common practice for fighting some ...
November 12, 2015
November 12, 2015 — A pharmacist-physician collaborative effort to control blood pressure among a diverse group of ...
November 12, 2015
November 11, 2015 — Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new ...
November 11, 2015
November 3, 2015 — Pulmonary embolism (PE) is a potentially life-threatening condition that occurs, for example, when a ...
November 03, 2015
October 23, 2015 — A randomized trial found that ranolazine did not reduce the composite rate of ischemia-driven ...
October 23, 2015October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior to ...
October 22, 2015
October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...
October 20, 2015
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab) ...
October 19, 2015
October 2, 2015 — AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies ...
October 02, 2015September 25, 2015 – The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial ...
September 25, 2015
September 15, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved Brilinta ...
September 15, 2015
September 11, 2015 — New Haven Pharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of ...
September 11, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now